Description
OCFS has the need to obtain the medication Trikafta in order to treat Cystic Fibrosis for an at-risk youth in custody. Trikafta treats the mutation causing cystic fibrosis. It not only improves symptoms but slows the progression of the disease overall. It has been abreakthrough medication for people with cystic fibrosis, allowing them to plan on living longer and to participate in life more fully. Trikafta is a specialty medication that can only be filled by a specialty pharmacy.
Attached files
The solicitation documents live at the source — open the bid source above to download them.